Food News and Research

RSS

Bt modification in maize does not affect beneficial microorganisms

Bt modification in maize does not affect non-target beneficial microorganisms such as endophytes. Although Bt maize is one of the most popular GM crops in the world, little is known about potential impacts on ecosystem functionalities.

30 Jul 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter continues to expand portfolio of clinical flow cytometry solutions with its latest innovations.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Study finds tick bite meat allergy as most common cause of anaphylaxis

An increase in the Lone Star tick population since 2006, and the ability to recognize the ticks as the source of "alpha gal" allergy to red meat has meant significantly more cases of anaphylaxis being properly identified.

30 Jul 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.

28 Jul 2018

NIFA offers grants to South Dakota food scientist to improve quality of oats

Food scientist Padu Krishnan, a professor in the South Dakota State University Department of Dairy and Food Science, has received a three-year, nearly $450,000 National Institute of Food and Agriculture grant from the U.S. Department of Agriculture.

28 Jul 2018

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body’s cells of energy.

27 Jul 2018

Researchers investigate reason for increase in bariatric surgery wait times

Diagnosed with type 2 diabetes, high cholesterol and borderline high blood pressure, Dana Hayes pursued bariatric surgery in hopes of living a healthier life.

27 Jul 2018

DFG to honor two researchers with Ursula M. Händel Animal Welfare Prize

Prof. Dr. Ellen Fritsche, a toxicologist from the Leibniz Research Institute for Environmental Medicine at Heinrich Heine University Düsseldorf, and PD Dr. Dr. Hamid Reza Noori, a mathematician, physicist and medical scientist from the Max Planck Institute for Biological Cybernetics in Tübingen, are to be presented with the Ursula M. Händel Animal Welfare Prize by the Deutsche Forschungsgemeinschaft.

27 Jul 2018

New technique offers most accurate, efficient way for detecting nucleation

As a solution evaporates, the dissolved chemicals concentrate until they begin forming a crystal through a process called nucleation

27 Jul 2018

Fucose-based food supplement could be used to stop the spread of norovirus in children's hospitals

Norovirus is the most common cause of gastroenteritis worldwide; it causes tens hundreds of thousands of deaths each year and is particularly risky for children under 3 years old.

27 Jul 2018

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

27 Jul 2018

Researchers discover novel antibiotic from leaf of common weed

Researchers working on an SNSF project have discovered novel, antibiotically active chemical substances in a previously rarely explored site: the leaf of a common field weed.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

Dermatologist explains whether dietary changes could impact skin health

They say you are what you eat, but it's not quite that simple when it comes to healthy skin.

27 Jul 2018

Qualification of first Parkinson's biomarker represents major milestone in clinical trials

The biomarker is used to determine the presence of dopamine transport deficiency in the brain, and has been qualified as an enrichment biomarker for clinical trials targeting early stages of Parkinson's, soon after diagnosis

27 Jul 2018

Eliminating malaria-carrying mosquitoes does not impact ecosystem, shows study

By combining studies on one species of malaria-carrying mosquito, researchers found that no other animals rely solely on them for food.

27 Jul 2018

Brain's response to taste stimuli could play role in driving anorexia nervosa

Researchers at the University of Colorado Anschutz Medical Campus have found that the brain's response to taste stimuli is linked to high anxiety and a drive for thinness that could play a role in driving anorexia nervosa.

27 Jul 2018

Surrey researchers design more efficient, flexible x-ray detector

Detectors that are presently used for mammograms and for dose measurements in radiotherapy are often rigid, causing errors in screening, or dose delivery to surrounding healthy tissue.

26 Jul 2018

Study helps to explain why older adults experience dysphagia

As adults age, they all experience a natural loss of muscle mass and function. A new study finds that as the loss of muscle and function in the throat occurs it becomes more difficult for efficient constriction to occur while swallowing - which leads to an increased chance of food and liquids being left over in the throat.

26 Jul 2018

CERENOVUS announces launch of novel stent retriever for treating stroke patients

CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.

26 Jul 2018